AdvaMed Statement on the Klomp Nomination
- Coverage & Payment
- Diagnostics
- Digital Health
- Government & Legislative Affairs
- Health Access
- Regulatory Affairs
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the largest trade association representing medtech innovators, posted his statement on LinkedIn regarding the nomination of Chris Klomp as deputy secretary of the Department of Health and Human Services:
https://www.linkedin.com/feed/update/urn:li:share:7476339373047951360/
Related Reading
Blog / Coverage & Payment / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs
Essential Tremor Treatment: A Sensible Solution, Possibly Driven Out of Reach
June 22, 2026
Millions of Americans have the neurological condition essential tremor. Often, that means their hand shakes so badly, they can’t hold a pen, fork, or glass of water. Every activity of daily living is compromised, day and night.
Resource / China / Global & Trade / Regulatory Affairs / Standards
China GMP and ISO 13485: A Side-by-Side Comparison
June 22, 2026
China GMP and ISO 13485: A Side-by-Side Comparison
Digital Health
AdvaMed® Digital Health Tech™ Members
The following companies are members ofAdvaMed® Digital Health Tech™.
Event / Health Access
Current Trends and Opportunities in Women’s Health
June 30, 2026
1:00 PM – 2:00 PM
Don’t miss this timely discussion of trends in women’s health, recent developments, emerging opportunities, and current challenges.
Event / Regulatory Affairs
Accelerating Medtech Innovation Through AI-Enabled Product Development
June 24, 2026
12:00 PM – 1:00 PM
Join Kearney as they explore how medtech organizations are using AI to transform product development and accelerate innovation.
Blog / Coverage & Payment / Digital Health / Government & Legislative Affairs / Health Access / Medical Imaging
AdvaMed-Supported State Legislative Wins Advance Patient Access Across the U.S.
June 1, 2026
Millions of patients’ lives are improved every day because of advancements in medical technology. But too often, gaps in coverage and access prevent patients from benefiting from the safe, effective, and innovative technologies that can help detect disease earlier, improve treatment, and support better outcomes.
That is why AdvaMed’s 2026 Patients First Agenda focuses on supporting policies that put patients at the center of health care. Across the country, AdvaMed works alongside patient advocacy group partners to help address gaps in access and coverage for critical medical technologies and bring innovative care to patients and families when they need it most.
Event / Regulatory Affairs
Accelerating ASC Transition and Medtech Commercial Model Imperatives
July 21, 2026
11:00 AM – 12:00 PM
Explore ASC growth trends, buyer dynamics & go-to-market strategies for medtech manufacturers in this webinar with Alexander Group.
Resource / Diagnostics / Regulatory Affairs
Clinical Evidence for IVD Medical Devices
May 22, 2026
AdvaMed’s feedback on the CEIVD draft outlines targeted recommendations to improve clarity in clinical evidence expectations for IVD devices, including more precise terminology, alignment with global frameworks, and clearer distinctions between real-world data and evidence.
Call to Action Heading…
Call to Action Description…